13% reported smaller profit than expected in the fourth quarter and predicted earnings for 2019 would be substantially lower than analysts' projections Tuesday, pushing shares down more than 6% in late trading. The pharmaceutical giant reported fourth-quarter earnings of $51.2 million, or 10 cents a share, on sales of $3.08 billion, down from $3.24 billion a year ago. After taking out restructuring charges and other costs, the company claimed adjusted earnings of $1.30 a share, down from $1.
For 2019, Bresch promised "a strong top-line financial performance," but the bottom line again looks problematic. Mylan forecast adjusted earnings of $3.80 a share to $4.80 a share on revenue of $11.5 billion to $12.5 billion, while analysts on average were predicting 2019 adjusted profit of $5.03 a share on revenue of $11.79 billion, according to FactSet. Mylan previously guided for 2019 revenue of $11.25 billion to $12.25 billion. Mylan shares closed with a 1.1% decline at $30.
United States United States Latest News, United States United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: MarketWatch - 🏆 3. / 97 Read more »
Source: MarketWatch - 🏆 3. / 97 Read more »
Macy's shares rise after earnings and sales beat expectationsIt’s the ap!
Source: MarketWatch - 🏆 3. / 97 Read more »
Source: MarketWatch - 🏆 3. / 97 Read more »
Source: WSJ - 🏆 98. / 63 Read more »
Home Depot forecasts poor 2019 earnings as U.S. housing momentum slowsHome Depot Inc projected 2019 earnings below Wall Street forecasts on Tuesday, a... That's sounds like rally time! Meanwhile, home builders ETF $XHB up 19% this year. Time for a short? Methinks so. Wonder how many folks are boycotting HD because its owner is a Trump supporter? I am
Source: Reuters - 🏆 2. / 97 Read more »